Lifeng Luo

602 total citations
34 papers, 487 citations indexed

About

Lifeng Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Lifeng Luo has authored 34 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Biomaterials. Recurrent topics in Lifeng Luo's work include Nanoparticle-Based Drug Delivery (8 papers), Advanced Drug Delivery Systems (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Lifeng Luo is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Advanced Drug Delivery Systems (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Lifeng Luo collaborates with scholars based in China, Netherlands and Macao. Lifeng Luo's co-authors include Xing Tang, Yu Zhang, Tian Yin, Haibing He, Jianfeng Weng, Jingxin Gou, Qiuyue Chen, Ran Zeng, Yi Xiang and Linlin Miao and has published in prestigious journals such as ACS Nano, ACS Catalysis and Journal of Colloid and Interface Science.

In The Last Decade

Lifeng Luo

30 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifeng Luo China 14 156 112 96 81 59 34 487
Jiagang Liu China 12 206 1.3× 87 0.8× 68 0.7× 69 0.9× 53 0.9× 46 520
Yanna Liu China 16 281 1.8× 87 0.8× 40 0.4× 47 0.6× 54 0.9× 26 643
Zuhong Tian China 12 373 2.4× 92 0.8× 92 1.0× 42 0.5× 81 1.4× 20 715
Yanhua Tang China 14 301 1.9× 115 1.0× 58 0.6× 58 0.7× 53 0.9× 47 777
Liwen Li China 11 230 1.5× 48 0.4× 43 0.4× 35 0.4× 56 0.9× 21 398
Dina H. Kassem Egypt 14 209 1.3× 47 0.4× 117 1.2× 46 0.6× 34 0.6× 32 587
Haitao Yin China 12 353 2.3× 123 1.1× 39 0.4× 115 1.4× 76 1.3× 18 623
Wenjing Lai China 13 296 1.9× 75 0.7× 45 0.5× 69 0.9× 57 1.0× 36 583
Yan Xiong China 17 206 1.3× 34 0.3× 134 1.4× 66 0.8× 30 0.5× 46 798
Kensuke Suzuki Japan 10 85 0.5× 94 0.8× 45 0.5× 52 0.6× 49 0.8× 25 458

Countries citing papers authored by Lifeng Luo

Since Specialization
Citations

This map shows the geographic impact of Lifeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Luo more than expected).

Fields of papers citing papers by Lifeng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Luo. The network helps show where Lifeng Luo may publish in the future.

Co-authorship network of co-authors of Lifeng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Lifeng Luo. A scholar is included among the top collaborators of Lifeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifeng Luo. Lifeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Zhi-Jie, et al.. (2025). Glucose-modified PEG-PLA self-assembled nano-micelles optimize DOX enrichment, tissue penetration, and tumor suppression effects in pancreatic ductal adenocarcinoma. Journal of Drug Delivery Science and Technology. 110. 107073–107073. 1 indexed citations
2.
Li, Tongtong, et al.. (2025). Photo and earth-abundant metal dual catalysis in organic synthesis. Organic Chemistry Frontiers. 12(16). 4530–4607. 5 indexed citations
3.
4.
Li, Tongtong, Lifeng Luo, Xiaokai Cheng, & Zhan Lu. (2024). Enantiocovergent Cross-Coupling Reaction with 1,4-Dihydropyridine Derivatives via Photoinduced Nickel Catalysis. ACS Catalysis. 14(5). 3278–3286. 13 indexed citations
5.
Luo, Lifeng, Ling Zhou, Ziwei Xu, et al.. (2024). Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities. Cancer Cell International. 24(1). 84–84. 1 indexed citations
6.
Wu, Huayu, et al.. (2023). Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma. World Journal of Surgical Oncology. 21(1). 366–366. 1 indexed citations
7.
Tao, Feng, Qingsong Ye, Lifeng Luo, et al.. (2023). Antigen-loaded flagellate bacteria for enhanced adaptive immune response by intradermal injection. Journal of Controlled Release. 364. 562–575.
8.
Luo, Lifeng, Zhong Chen, Qingsong Ye, et al.. (2023). Cytosolic perfluorocarbon delivery to platelets via albumin for antithrombotic therapy. Journal of Controlled Release. 355. 109–121. 6 indexed citations
9.
Bao, Zhiyao, Lifeng Luo, Tian Xu, et al.. (2022). Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study. Annals of Translational Medicine. 10(18). 967–967. 5 indexed citations
10.
Liang, Zhi-Jie, Yan Wan, Donglin Huang, et al.. (2021). Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression. Frontiers in Oncology. 11. 569295–569295. 56 indexed citations
11.
Zeng, Ran, Fang Liu, Jin Yang, et al.. (2021). PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients. Frontiers in Immunology. 12. 724443–724443. 50 indexed citations
12.
Zeng, Ran, Lifeng Luo, Zhiyao Bao, et al.. (2021). EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAFV600E mutation: a case report and review of literature. Cancer Drug Resistance. 4(4). 1019–1027. 6 indexed citations
13.
Luo, Lifeng, Qiuyue Chen, Yi Liu, et al.. (2019). The modulation of drug-loading stability within lipid membranes via medium chain triglycerides incorporation. International Journal of Pharmaceutics. 566. 371–382. 4 indexed citations
14.
Liu, Xiaoyu, Lifeng Luo, Qi Pan, et al.. (2019). A Comprehensive Preclinical Evaluation of Intravenous Etoposide Lipid Emulsion. Pharmaceutical Research. 36(7). 96–96. 3 indexed citations
15.
Luo, Lifeng, Qiuyue Chen, Lu Liu, et al.. (2018). Capacity of cholesteryl hemisuccinate in ion pair/phospholipid complex to improve drug-loading, stability and antibacterial activity of clarithromycin intravenous lipid microsphere. Colloids and Surfaces B Biointerfaces. 172. 262–271. 12 indexed citations
16.
Du, Quan, Jianfeng Weng, Lifeng Luo, et al.. (2018). Serum ST2 as a potential prognostic biomarker for traumatic brain injury. Clinica Chimica Acta. 487. 145–152. 23 indexed citations
17.
Tian, Lei, Linlin Miao, Wei Chu, et al.. (2018). Disulfiram-loaded mixed nanoparticles with high drug-loading and plasma stability by reducing the core crystallinity for intravenous delivery. Journal of Colloid and Interface Science. 529. 34–43. 41 indexed citations
18.
Luo, Lifeng, Xiuzhi Wang, Qiuyue Chen, et al.. (2017). A parenteral docetaxel-loaded lipid microsphere with decreased 7-epidocetaxel conversion in vitro and in vivo. European Journal of Pharmaceutical Sciences. 109. 638–649. 12 indexed citations
19.
Chen, Jun, et al.. (2012). Change in plasma visfatin level after severe traumatic brain injury. Peptides. 38(1). 8–12. 21 indexed citations
20.
Ye, Caiying, Rui Jü, Lifeng Luo, et al.. (2012). Carboxyamidotriazole Ameliorates Experimental Colitis by Inhibition of Cytokine Production, Nuclear Factor-κB Activation, and Colonic Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 342(2). 356–365. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiagang Liu Breakdown of academic impact, for papers by Yanna Liu Breakdown of academic impact, for papers by Zuhong Tian Breakdown of academic impact, for papers by Yanhua Tang Breakdown of academic impact, for papers by Liwen Li Breakdown of academic impact, for papers by Dina H. Kassem Breakdown of academic impact, for papers by Haitao Yin Breakdown of academic impact, for papers by Wenjing Lai Breakdown of academic impact, for papers by Yan Xiong Breakdown of academic impact, for papers by Kensuke Suzuki
Rankless by CCL
2026